Meta-DOT
Jump to navigation
Jump to search
| File:Meta-DOT.png | |
| Clinical data | |
|---|---|
| Other names | 5-Methylthio-2,4-dimethoxyamphetamine; 2,4-Dimethoxy-5-methylthioamphetamine |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C12H19NO2S |
| Molar mass | 241.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
Meta-DOT, also known as 5-methylthio-2,4-dimethoxyamphetamine, is a drug.[1] It is similar in structure to TMA-2.[1] Meta-DOT was first synthesized by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dose is listed as 35 mg, and the duration unknown.[1] Meta-DOT produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Meta-DOT.[1]
